nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—ADRA2A—Amitriptyline—migraine	0.209	0.391	CbGbCtD
Guanabenz—CYP1A2—Propranolol—migraine	0.0975	0.182	CbGbCtD
Guanabenz—CYP1A2—Amitriptyline—migraine	0.0843	0.158	CbGbCtD
Guanabenz—CYP1A2—Valproic Acid—migraine	0.0768	0.144	CbGbCtD
Guanabenz—CYP1A2—Verapamil—migraine	0.0669	0.125	CbGbCtD
Guanabenz—ADRA2C—Amine ligand-binding receptors—HTR2A—migraine	0.000849	0.00691	CbGpPWpGaD
Guanabenz—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000847	0.0069	CbGpPWpGaD
Guanabenz—ADRA2A—Monoamine GPCRs—HTR2A—migraine	0.00082	0.00668	CbGpPWpGaD
Guanabenz—ADRA2A—Amine ligand-binding receptors—HTR2A—migraine	0.00069	0.00562	CbGpPWpGaD
Guanabenz—ADRA2B—G alpha (i) signalling events—HTR1D—migraine	0.000651	0.0053	CbGpPWpGaD
Guanabenz—ADRA2C—G alpha (i) signalling events—HTR1D—migraine	0.000608	0.00495	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000604	0.00492	CbGpPWpGaD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000564	0.00459	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000561	0.00457	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—RAMP1—migraine	0.000542	0.00442	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—CALCRL—migraine	0.000542	0.00442	CbGpPWpGaD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000524	0.00427	CbGpPWpGaD
Guanabenz—Immune system disorder—Timolol—migraine	0.000524	0.00153	CcSEcCtD
Guanabenz—Hypersensitivity—Propranolol—migraine	0.000523	0.00153	CcSEcCtD
Guanabenz—Mediastinal disorder—Timolol—migraine	0.000523	0.00153	CcSEcCtD
Guanabenz—Agitation—Valproic Acid—migraine	0.000521	0.00152	CcSEcCtD
Guanabenz—Urticaria—Verapamil—migraine	0.000519	0.00151	CcSEcCtD
Guanabenz—Angioedema—Valproic Acid—migraine	0.000518	0.00151	CcSEcCtD
Guanabenz—Nausea—Amitriptyline—migraine	0.000518	0.00151	CcSEcCtD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000517	0.00421	CbGpPWpGaD
Guanabenz—Weight increased—Topiramate—migraine	0.000517	0.00151	CcSEcCtD
Guanabenz—Weight decreased—Topiramate—migraine	0.000514	0.0015	CcSEcCtD
Guanabenz—Hyperglycaemia—Topiramate—migraine	0.000512	0.00149	CcSEcCtD
Guanabenz—Malaise—Valproic Acid—migraine	0.000512	0.00149	CcSEcCtD
Guanabenz—Erythema multiforme—Gabapentin—migraine	0.000511	0.00149	CcSEcCtD
Guanabenz—Asthenia—Propranolol—migraine	0.000509	0.00149	CcSEcCtD
Guanabenz—Leukopenia—Valproic Acid—migraine	0.000508	0.00148	CcSEcCtD
Guanabenz—ADRA2C—GPCR ligand binding—CALCRL—migraine	0.000507	0.00413	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—RAMP1—migraine	0.000507	0.00413	CbGpPWpGaD
Guanabenz—Infestation—Topiramate—migraine	0.000506	0.00148	CcSEcCtD
Guanabenz—Infestation NOS—Topiramate—migraine	0.000506	0.00148	CcSEcCtD
Guanabenz—Malnutrition—Timolol—migraine	0.000505	0.00147	CcSEcCtD
Guanabenz—Erythema—Timolol—migraine	0.000505	0.00147	CcSEcCtD
Guanabenz—Eye disorder—Gabapentin—migraine	0.000505	0.00147	CcSEcCtD
Guanabenz—Tinnitus—Gabapentin—migraine	0.000504	0.00147	CcSEcCtD
Guanabenz—Tension—Timolol—migraine	0.000496	0.00145	CcSEcCtD
Guanabenz—Cough—Valproic Acid—migraine	0.000495	0.00144	CcSEcCtD
Guanabenz—ADRA2A—G alpha (i) signalling events—HTR1D—migraine	0.000494	0.00402	CbGpPWpGaD
Guanabenz—Nervousness—Timolol—migraine	0.00049	0.00143	CcSEcCtD
Guanabenz—Hypertension—Valproic Acid—migraine	0.00049	0.00143	CcSEcCtD
Guanabenz—Immune system disorder—Gabapentin—migraine	0.000488	0.00142	CcSEcCtD
Guanabenz—Mediastinal disorder—Gabapentin—migraine	0.000487	0.00142	CcSEcCtD
Guanabenz—Diarrhoea—Propranolol—migraine	0.000486	0.00142	CcSEcCtD
Guanabenz—Chills—Gabapentin—migraine	0.000485	0.00141	CcSEcCtD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000483	0.00394	CbGpPWpGaD
Guanabenz—Myalgia—Valproic Acid—migraine	0.000483	0.00141	CcSEcCtD
Guanabenz—Chest pain—Valproic Acid—migraine	0.000483	0.00141	CcSEcCtD
Guanabenz—Arthralgia—Valproic Acid—migraine	0.000483	0.00141	CcSEcCtD
Guanabenz—Anxiety—Valproic Acid—migraine	0.000481	0.0014	CcSEcCtD
Guanabenz—Hypersensitivity—Verapamil—migraine	0.000481	0.0014	CcSEcCtD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000481	0.00392	CbGpPWpGaD
Guanabenz—Discomfort—Valproic Acid—migraine	0.000477	0.00139	CcSEcCtD
Guanabenz—Vision blurred—Timolol—migraine	0.000476	0.00139	CcSEcCtD
Guanabenz—Dry mouth—Valproic Acid—migraine	0.000472	0.00138	CcSEcCtD
Guanabenz—Erythema—Gabapentin—migraine	0.00047	0.00137	CcSEcCtD
Guanabenz—Malnutrition—Gabapentin—migraine	0.00047	0.00137	CcSEcCtD
Guanabenz—Dizziness—Propranolol—migraine	0.000469	0.00137	CcSEcCtD
Guanabenz—Asthenia—Verapamil—migraine	0.000468	0.00137	CcSEcCtD
Guanabenz—Confusional state—Valproic Acid—migraine	0.000467	0.00136	CcSEcCtD
Guanabenz—Flatulence—Gabapentin—migraine	0.000463	0.00135	CcSEcCtD
Guanabenz—Oedema—Valproic Acid—migraine	0.000463	0.00135	CcSEcCtD
Guanabenz—Pruritus—Verapamil—migraine	0.000462	0.00135	CcSEcCtD
Guanabenz—Tension—Gabapentin—migraine	0.000461	0.00135	CcSEcCtD
Guanabenz—Angioedema—Timolol—migraine	0.000461	0.00135	CcSEcCtD
Guanabenz—Infection—Valproic Acid—migraine	0.00046	0.00134	CcSEcCtD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000458	0.00373	CbGpPWpGaD
Guanabenz—Haemoglobin—Topiramate—migraine	0.000457	0.00133	CcSEcCtD
Guanabenz—Nervousness—Gabapentin—migraine	0.000457	0.00133	CcSEcCtD
Guanabenz—Back pain—Gabapentin—migraine	0.000455	0.00133	CcSEcCtD
Guanabenz—Haemorrhage—Topiramate—migraine	0.000454	0.00133	CcSEcCtD
Guanabenz—Nervous system disorder—Valproic Acid—migraine	0.000454	0.00132	CcSEcCtD
Guanabenz—Thrombocytopenia—Valproic Acid—migraine	0.000453	0.00132	CcSEcCtD
Guanabenz—Syncope—Timolol—migraine	0.000453	0.00132	CcSEcCtD
Guanabenz—Muscle spasms—Gabapentin—migraine	0.000452	0.00132	CcSEcCtD
Guanabenz—Tachycardia—Valproic Acid—migraine	0.000452	0.00132	CcSEcCtD
Guanabenz—Vomiting—Propranolol—migraine	0.000451	0.00132	CcSEcCtD
Guanabenz—Skin disorder—Valproic Acid—migraine	0.00045	0.00131	CcSEcCtD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000449	0.00366	CbGpPWpGaD
Guanabenz—Oedema peripheral—Topiramate—migraine	0.000448	0.00131	CcSEcCtD
Guanabenz—Rash—Propranolol—migraine	0.000448	0.00131	CcSEcCtD
Guanabenz—Dermatitis—Propranolol—migraine	0.000447	0.0013	CcSEcCtD
Guanabenz—Diarrhoea—Verapamil—migraine	0.000447	0.0013	CcSEcCtD
Guanabenz—Connective tissue disorder—Topiramate—migraine	0.000447	0.0013	CcSEcCtD
Guanabenz—Loss of consciousness—Timolol—migraine	0.000444	0.00129	CcSEcCtD
Guanabenz—Vision blurred—Gabapentin—migraine	0.000443	0.00129	CcSEcCtD
Guanabenz—Anorexia—Valproic Acid—migraine	0.000441	0.00129	CcSEcCtD
Guanabenz—Cough—Timolol—migraine	0.000441	0.00129	CcSEcCtD
Guanabenz—Ill-defined disorder—Gabapentin—migraine	0.000436	0.00127	CcSEcCtD
Guanabenz—Hypertension—Timolol—migraine	0.000436	0.00127	CcSEcCtD
Guanabenz—Anaemia—Gabapentin—migraine	0.000435	0.00127	CcSEcCtD
Guanabenz—Hypotension—Valproic Acid—migraine	0.000433	0.00126	CcSEcCtD
Guanabenz—Agitation—Gabapentin—migraine	0.000432	0.00126	CcSEcCtD
Guanabenz—Dizziness—Verapamil—migraine	0.000432	0.00126	CcSEcCtD
Guanabenz—Myalgia—Timolol—migraine	0.00043	0.00125	CcSEcCtD
Guanabenz—Chest pain—Timolol—migraine	0.00043	0.00125	CcSEcCtD
Guanabenz—Arthralgia—Timolol—migraine	0.00043	0.00125	CcSEcCtD
Guanabenz—Erythema multiforme—Topiramate—migraine	0.00043	0.00125	CcSEcCtD
Guanabenz—Angioedema—Gabapentin—migraine	0.00043	0.00125	CcSEcCtD
Guanabenz—Anxiety—Timolol—migraine	0.000428	0.00125	CcSEcCtD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000426	0.00347	CbGpPWpGaD
Guanabenz—Discomfort—Timolol—migraine	0.000425	0.00124	CcSEcCtD
Guanabenz—Eye disorder—Topiramate—migraine	0.000425	0.00124	CcSEcCtD
Guanabenz—Malaise—Gabapentin—migraine	0.000424	0.00124	CcSEcCtD
Guanabenz—Tinnitus—Topiramate—migraine	0.000424	0.00124	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Valproic Acid—migraine	0.000422	0.00123	CcSEcCtD
Guanabenz—Syncope—Gabapentin—migraine	0.000422	0.00123	CcSEcCtD
Guanabenz—Nausea—Propranolol—migraine	0.000422	0.00123	CcSEcCtD
Guanabenz—Leukopenia—Gabapentin—migraine	0.000421	0.00123	CcSEcCtD
Guanabenz—Dry mouth—Timolol—migraine	0.00042	0.00123	CcSEcCtD
Guanabenz—Paraesthesia—Valproic Acid—migraine	0.000416	0.00121	CcSEcCtD
Guanabenz—Confusional state—Timolol—migraine	0.000416	0.00121	CcSEcCtD
Guanabenz—Vomiting—Verapamil—migraine	0.000415	0.00121	CcSEcCtD
Guanabenz—Loss of consciousness—Gabapentin—migraine	0.000413	0.00121	CcSEcCtD
Guanabenz—Dyspnoea—Valproic Acid—migraine	0.000413	0.0012	CcSEcCtD
Guanabenz—Oedema—Timolol—migraine	0.000412	0.0012	CcSEcCtD
Guanabenz—Rash—Verapamil—migraine	0.000412	0.0012	CcSEcCtD
Guanabenz—ADRA2A—GPCR ligand binding—CALCRL—migraine	0.000411	0.00335	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—RAMP1—migraine	0.000411	0.00335	CbGpPWpGaD
Guanabenz—Dermatitis—Verapamil—migraine	0.000411	0.0012	CcSEcCtD
Guanabenz—Immune system disorder—Topiramate—migraine	0.00041	0.0012	CcSEcCtD
Guanabenz—Cough—Gabapentin—migraine	0.00041	0.0012	CcSEcCtD
Guanabenz—Mediastinal disorder—Topiramate—migraine	0.00041	0.00119	CcSEcCtD
Guanabenz—Infection—Timolol—migraine	0.000409	0.00119	CcSEcCtD
Guanabenz—Headache—Verapamil—migraine	0.000409	0.00119	CcSEcCtD
Guanabenz—Chills—Topiramate—migraine	0.000408	0.00119	CcSEcCtD
Guanabenz—Dyspepsia—Valproic Acid—migraine	0.000408	0.00119	CcSEcCtD
Guanabenz—Hypertension—Gabapentin—migraine	0.000406	0.00118	CcSEcCtD
Guanabenz—Shock—Timolol—migraine	0.000405	0.00118	CcSEcCtD
Guanabenz—Nervous system disorder—Timolol—migraine	0.000404	0.00118	CcSEcCtD
Guanabenz—Decreased appetite—Valproic Acid—migraine	0.000402	0.00117	CcSEcCtD
Guanabenz—Arthralgia—Gabapentin—migraine	0.0004	0.00117	CcSEcCtD
Guanabenz—Myalgia—Gabapentin—migraine	0.0004	0.00117	CcSEcCtD
Guanabenz—Chest pain—Gabapentin—migraine	0.0004	0.00117	CcSEcCtD
Guanabenz—Skin disorder—Timolol—migraine	0.0004	0.00117	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Valproic Acid—migraine	0.0004	0.00117	CcSEcCtD
Guanabenz—Fatigue—Valproic Acid—migraine	0.000399	0.00116	CcSEcCtD
Guanabenz—Anxiety—Gabapentin—migraine	0.000399	0.00116	CcSEcCtD
Guanabenz—Pain—Valproic Acid—migraine	0.000396	0.00115	CcSEcCtD
Guanabenz—Constipation—Valproic Acid—migraine	0.000396	0.00115	CcSEcCtD
Guanabenz—Erythema—Topiramate—migraine	0.000396	0.00115	CcSEcCtD
Guanabenz—Malnutrition—Topiramate—migraine	0.000396	0.00115	CcSEcCtD
Guanabenz—Discomfort—Gabapentin—migraine	0.000396	0.00115	CcSEcCtD
Guanabenz—ADRA2B—G alpha (i) signalling events—HTR1B—migraine	0.000394	0.00321	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—HTR1D—migraine	0.000394	0.00321	CbGpPWpGaD
Guanabenz—Anorexia—Timolol—migraine	0.000393	0.00115	CcSEcCtD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000393	0.0032	CbGpPWpGaD
Guanabenz—Dry mouth—Gabapentin—migraine	0.000392	0.00114	CcSEcCtD
Guanabenz—Flatulence—Topiramate—migraine	0.00039	0.00114	CcSEcCtD
Guanabenz—Tension—Topiramate—migraine	0.000388	0.00113	CcSEcCtD
Guanabenz—Nausea—Verapamil—migraine	0.000388	0.00113	CcSEcCtD
Guanabenz—Confusional state—Gabapentin—migraine	0.000387	0.00113	CcSEcCtD
Guanabenz—Hypotension—Timolol—migraine	0.000385	0.00112	CcSEcCtD
Guanabenz—Nervousness—Topiramate—migraine	0.000384	0.00112	CcSEcCtD
Guanabenz—Oedema—Gabapentin—migraine	0.000384	0.00112	CcSEcCtD
Guanabenz—Back pain—Topiramate—migraine	0.000383	0.00112	CcSEcCtD
Guanabenz—Feeling abnormal—Valproic Acid—migraine	0.000381	0.00111	CcSEcCtD
Guanabenz—Infection—Gabapentin—migraine	0.000381	0.00111	CcSEcCtD
Guanabenz—Muscle spasms—Topiramate—migraine	0.00038	0.00111	CcSEcCtD
Guanabenz—ADRA2B—G alpha (i) signalling events—HTR1A—migraine	0.00038	0.00309	CbGpPWpGaD
Guanabenz—Gastrointestinal pain—Valproic Acid—migraine	0.000379	0.0011	CcSEcCtD
Guanabenz—Shock—Gabapentin—migraine	0.000378	0.0011	CcSEcCtD
Guanabenz—Nervous system disorder—Gabapentin—migraine	0.000376	0.0011	CcSEcCtD
Guanabenz—Thrombocytopenia—Gabapentin—migraine	0.000376	0.0011	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Timolol—migraine	0.000375	0.0011	CcSEcCtD
Guanabenz—Tachycardia—Gabapentin—migraine	0.000375	0.00109	CcSEcCtD
Guanabenz—Vision blurred—Topiramate—migraine	0.000373	0.00109	CcSEcCtD
Guanabenz—Skin disorder—Gabapentin—migraine	0.000373	0.00109	CcSEcCtD
Guanabenz—Paraesthesia—Timolol—migraine	0.00037	0.00108	CcSEcCtD
Guanabenz—ADRA2C—G alpha (i) signalling events—HTR1B—migraine	0.000368	0.003	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—HTR1D—migraine	0.000368	0.003	CbGpPWpGaD
Guanabenz—Urticaria—Valproic Acid—migraine	0.000368	0.00107	CcSEcCtD
Guanabenz—Dyspnoea—Timolol—migraine	0.000367	0.00107	CcSEcCtD
Guanabenz—Ill-defined disorder—Topiramate—migraine	0.000367	0.00107	CcSEcCtD
Guanabenz—ADRA2B—GPCR ligand binding—HTR2B—migraine	0.000366	0.00298	CbGpPWpGaD
Guanabenz—Body temperature increased—Valproic Acid—migraine	0.000366	0.00107	CcSEcCtD
Guanabenz—Abdominal pain—Valproic Acid—migraine	0.000366	0.00107	CcSEcCtD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000366	0.00298	CbGpPWpGaD
Guanabenz—Anorexia—Gabapentin—migraine	0.000366	0.00107	CcSEcCtD
Guanabenz—Anaemia—Topiramate—migraine	0.000366	0.00107	CcSEcCtD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000365	0.00297	CbGpPWpGaD
Guanabenz—Agitation—Topiramate—migraine	0.000364	0.00106	CcSEcCtD
Guanabenz—Dyspepsia—Timolol—migraine	0.000363	0.00106	CcSEcCtD
Guanabenz—Hypotension—Gabapentin—migraine	0.000359	0.00105	CcSEcCtD
Guanabenz—Decreased appetite—Timolol—migraine	0.000358	0.00105	CcSEcCtD
Guanabenz—Malaise—Topiramate—migraine	0.000357	0.00104	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Timolol—migraine	0.000356	0.00104	CcSEcCtD
Guanabenz—Fatigue—Timolol—migraine	0.000355	0.00104	CcSEcCtD
Guanabenz—Syncope—Topiramate—migraine	0.000355	0.00104	CcSEcCtD
Guanabenz—ADRA2C—G alpha (i) signalling events—HTR1A—migraine	0.000355	0.00289	CbGpPWpGaD
Guanabenz—Leukopenia—Topiramate—migraine	0.000354	0.00103	CcSEcCtD
Guanabenz—Pain—Timolol—migraine	0.000352	0.00103	CcSEcCtD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000352	0.00287	CbGpPWpGaD
Guanabenz—Musculoskeletal discomfort—Gabapentin—migraine	0.00035	0.00102	CcSEcCtD
Guanabenz—Loss of consciousness—Topiramate—migraine	0.000348	0.00101	CcSEcCtD
Guanabenz—Cough—Topiramate—migraine	0.000345	0.00101	CcSEcCtD
Guanabenz—Paraesthesia—Gabapentin—migraine	0.000345	0.00101	CcSEcCtD
Guanabenz—ADRA2C—GPCR ligand binding—HTR2B—migraine	0.000342	0.00279	CbGpPWpGaD
Guanabenz—Dyspnoea—Gabapentin—migraine	0.000342	0.000998	CcSEcCtD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000342	0.00278	CbGpPWpGaD
Guanabenz—Hypertension—Topiramate—migraine	0.000342	0.000997	CcSEcCtD
Guanabenz—Hypersensitivity—Valproic Acid—migraine	0.000341	0.000995	CcSEcCtD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00034	0.00277	CbGpPWpGaD
Guanabenz—Feeling abnormal—Timolol—migraine	0.00034	0.000991	CcSEcCtD
Guanabenz—Dyspepsia—Gabapentin—migraine	0.000338	0.000986	CcSEcCtD
Guanabenz—Gastrointestinal pain—Timolol—migraine	0.000337	0.000983	CcSEcCtD
Guanabenz—Myalgia—Topiramate—migraine	0.000337	0.000983	CcSEcCtD
Guanabenz—Chest pain—Topiramate—migraine	0.000337	0.000983	CcSEcCtD
Guanabenz—Arthralgia—Topiramate—migraine	0.000337	0.000983	CcSEcCtD
Guanabenz—Anxiety—Topiramate—migraine	0.000336	0.000979	CcSEcCtD
Guanabenz—Decreased appetite—Gabapentin—migraine	0.000334	0.000973	CcSEcCtD
Guanabenz—Discomfort—Topiramate—migraine	0.000333	0.000971	CcSEcCtD
Guanabenz—Asthenia—Valproic Acid—migraine	0.000332	0.000969	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Gabapentin—migraine	0.000331	0.000967	CcSEcCtD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000331	0.00269	CbGpPWpGaD
Guanabenz—Fatigue—Gabapentin—migraine	0.000331	0.000965	CcSEcCtD
Guanabenz—Dry mouth—Topiramate—migraine	0.000329	0.000961	CcSEcCtD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000329	0.00268	CbGpPWpGaD
Guanabenz—Pain—Gabapentin—migraine	0.000328	0.000957	CcSEcCtD
Guanabenz—Constipation—Gabapentin—migraine	0.000328	0.000957	CcSEcCtD
Guanabenz—Pruritus—Valproic Acid—migraine	0.000328	0.000956	CcSEcCtD
Guanabenz—Urticaria—Timolol—migraine	0.000327	0.000955	CcSEcCtD
Guanabenz—Abdominal pain—Timolol—migraine	0.000326	0.00095	CcSEcCtD
Guanabenz—Body temperature increased—Timolol—migraine	0.000326	0.00095	CcSEcCtD
Guanabenz—Confusional state—Topiramate—migraine	0.000326	0.00095	CcSEcCtD
Guanabenz—Oedema—Topiramate—migraine	0.000323	0.000942	CcSEcCtD
Guanabenz—Infection—Topiramate—migraine	0.000321	0.000936	CcSEcCtD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000318	0.00259	CbGpPWpGaD
Guanabenz—Shock—Topiramate—migraine	0.000318	0.000927	CcSEcCtD
Guanabenz—Diarrhoea—Valproic Acid—migraine	0.000317	0.000924	CcSEcCtD
Guanabenz—Nervous system disorder—Topiramate—migraine	0.000317	0.000924	CcSEcCtD
Guanabenz—Feeling abnormal—Gabapentin—migraine	0.000316	0.000923	CcSEcCtD
Guanabenz—Thrombocytopenia—Topiramate—migraine	0.000316	0.000922	CcSEcCtD
Guanabenz—Tachycardia—Topiramate—migraine	0.000315	0.000919	CcSEcCtD
Guanabenz—Gastrointestinal pain—Gabapentin—migraine	0.000314	0.000916	CcSEcCtD
Guanabenz—Skin disorder—Topiramate—migraine	0.000314	0.000915	CcSEcCtD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000313	0.00255	CbGpPWpGaD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000309	0.00252	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000308	0.00251	CbGpPWpGaD
Guanabenz—Anorexia—Topiramate—migraine	0.000308	0.000898	CcSEcCtD
Guanabenz—ADRA2B—GPCR downstream signaling—RAMP1—migraine	0.000306	0.0025	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CALCRL—migraine	0.000306	0.0025	CbGpPWpGaD
Guanabenz—Dizziness—Valproic Acid—migraine	0.000306	0.000893	CcSEcCtD
Guanabenz—Urticaria—Gabapentin—migraine	0.000305	0.000889	CcSEcCtD
Guanabenz—Hypersensitivity—Timolol—migraine	0.000304	0.000886	CcSEcCtD
Guanabenz—Body temperature increased—Gabapentin—migraine	0.000303	0.000885	CcSEcCtD
Guanabenz—Abdominal pain—Gabapentin—migraine	0.000303	0.000885	CcSEcCtD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000302	0.00246	CbGpPWpGaD
Guanabenz—Hypotension—Topiramate—migraine	0.000302	0.00088	CcSEcCtD
Guanabenz—ADRA2A—G alpha (i) signalling events—HTR1B—migraine	0.000299	0.00244	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—HTR1D—migraine	0.000299	0.00243	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000298	0.00243	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000297	0.00242	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000297	0.00242	CbGpPWpGaD
Guanabenz—Asthenia—Timolol—migraine	0.000296	0.000863	CcSEcCtD
Guanabenz—Vomiting—Valproic Acid—migraine	0.000294	0.000859	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Topiramate—migraine	0.000294	0.000858	CcSEcCtD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000293	0.00238	CbGpPWpGaD
Guanabenz—Rash—Valproic Acid—migraine	0.000292	0.000852	CcSEcCtD
Guanabenz—Dermatitis—Valproic Acid—migraine	0.000292	0.000851	CcSEcCtD
Guanabenz—Pruritus—Timolol—migraine	0.000292	0.000851	CcSEcCtD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000291	0.00237	CbGpPWpGaD
Guanabenz—Headache—Valproic Acid—migraine	0.00029	0.000846	CcSEcCtD
Guanabenz—Paraesthesia—Topiramate—migraine	0.00029	0.000846	CcSEcCtD
Guanabenz—ADRA2A—G alpha (i) signalling events—HTR1A—migraine	0.000288	0.00235	CbGpPWpGaD
Guanabenz—Dyspnoea—Topiramate—migraine	0.000288	0.00084	CcSEcCtD
Guanabenz—ADRA2C—GPCR downstream signaling—RAMP1—migraine	0.000286	0.00233	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CALCRL—migraine	0.000286	0.00233	CbGpPWpGaD
Guanabenz—Dyspepsia—Topiramate—migraine	0.000284	0.000829	CcSEcCtD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000283	0.00231	CbGpPWpGaD
Guanabenz—Hypersensitivity—Gabapentin—migraine	0.000283	0.000825	CcSEcCtD
Guanabenz—Diarrhoea—Timolol—migraine	0.000282	0.000823	CcSEcCtD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000282	0.0023	CbGpPWpGaD
Guanabenz—Decreased appetite—Topiramate—migraine	0.000281	0.000819	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Topiramate—migraine	0.000279	0.000813	CcSEcCtD
Guanabenz—Fatigue—Topiramate—migraine	0.000278	0.000812	CcSEcCtD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000278	0.00227	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—RAMP1—migraine	0.000278	0.00227	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CALCRL—migraine	0.000278	0.00227	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—HTR2B—migraine	0.000278	0.00226	CbGpPWpGaD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000278	0.00226	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000278	0.00226	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000278	0.00226	CbGpPWpGaD
Guanabenz—Constipation—Topiramate—migraine	0.000276	0.000806	CcSEcCtD
Guanabenz—Pain—Topiramate—migraine	0.000276	0.000806	CcSEcCtD
Guanabenz—Asthenia—Gabapentin—migraine	0.000275	0.000803	CcSEcCtD
Guanabenz—Nausea—Valproic Acid—migraine	0.000275	0.000802	CcSEcCtD
Guanabenz—Dizziness—Timolol—migraine	0.000273	0.000795	CcSEcCtD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000272	0.00222	CbGpPWpGaD
Guanabenz—Pruritus—Gabapentin—migraine	0.000272	0.000792	CcSEcCtD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000267	0.00218	CbGpPWpGaD
Guanabenz—Feeling abnormal—Topiramate—migraine	0.000266	0.000776	CcSEcCtD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000265	0.00216	CbGpPWpGaD
Guanabenz—Gastrointestinal pain—Topiramate—migraine	0.000264	0.00077	CcSEcCtD
Guanabenz—Diarrhoea—Gabapentin—migraine	0.000263	0.000766	CcSEcCtD
Guanabenz—Vomiting—Timolol—migraine	0.000262	0.000764	CcSEcCtD
Guanabenz—ADRA2C—Signaling by GPCR—RAMP1—migraine	0.00026	0.00212	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CALCRL—migraine	0.00026	0.00212	CbGpPWpGaD
Guanabenz—Rash—Timolol—migraine	0.00026	0.000758	CcSEcCtD
Guanabenz—Dermatitis—Timolol—migraine	0.00026	0.000757	CcSEcCtD
Guanabenz—Headache—Timolol—migraine	0.000258	0.000753	CcSEcCtD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000258	0.0021	CbGpPWpGaD
Guanabenz—Urticaria—Topiramate—migraine	0.000257	0.000748	CcSEcCtD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000255	0.00208	CbGpPWpGaD
Guanabenz—Abdominal pain—Topiramate—migraine	0.000255	0.000745	CcSEcCtD
Guanabenz—Body temperature increased—Topiramate—migraine	0.000255	0.000745	CcSEcCtD
Guanabenz—Dizziness—Gabapentin—migraine	0.000254	0.00074	CcSEcCtD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000251	0.00204	CbGpPWpGaD
Guanabenz—Nausea—Timolol—migraine	0.000245	0.000714	CcSEcCtD
Guanabenz—Vomiting—Gabapentin—migraine	0.000244	0.000712	CcSEcCtD
Guanabenz—Rash—Gabapentin—migraine	0.000242	0.000706	CcSEcCtD
Guanabenz—Dermatitis—Gabapentin—migraine	0.000242	0.000705	CcSEcCtD
Guanabenz—Headache—Gabapentin—migraine	0.00024	0.000701	CcSEcCtD
Guanabenz—ADRA2B—GPCR ligand binding—HTR1B—migraine	0.000239	0.00194	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000238	0.00194	CbGpPWpGaD
Guanabenz—Hypersensitivity—Topiramate—migraine	0.000238	0.000694	CcSEcCtD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000238	0.00194	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—RAMP1—migraine	0.000233	0.00189	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CALCRL—migraine	0.000233	0.00189	CbGpPWpGaD
Guanabenz—Asthenia—Topiramate—migraine	0.000232	0.000676	CcSEcCtD
Guanabenz—ADRA2B—GPCR ligand binding—HTR1A—migraine	0.00023	0.00187	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000229	0.00186	CbGpPWpGaD
Guanabenz—Pruritus—Topiramate—migraine	0.000228	0.000666	CcSEcCtD
Guanabenz—Nausea—Gabapentin—migraine	0.000228	0.000665	CcSEcCtD
Guanabenz—ADRA2B—GPCR ligand binding—NPS—migraine	0.000226	0.00184	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—TAC1—migraine	0.000226	0.00184	CbGpPWpGaD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000226	0.00184	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000225	0.00184	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000225	0.00184	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—HTR1B—migraine	0.000223	0.00182	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—HTR1D—migraine	0.000223	0.00181	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—HTR2C—migraine	0.000222	0.00181	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000221	0.0018	CbGpPWpGaD
Guanabenz—Diarrhoea—Topiramate—migraine	0.000221	0.000645	CcSEcCtD
Guanabenz—ADRA2B—GPCR ligand binding—EDNRA—migraine	0.000216	0.00176	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000215	0.00175	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—HTR1A—migraine	0.000215	0.00175	CbGpPWpGaD
Guanabenz—Dizziness—Topiramate—migraine	0.000214	0.000623	CcSEcCtD
Guanabenz—ADRA2C—GPCR ligand binding—TAC1—migraine	0.000211	0.00172	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—NPS—migraine	0.000211	0.00172	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—RAMP1—migraine	0.000211	0.00172	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CALCRL—migraine	0.000211	0.00172	CbGpPWpGaD
Guanabenz—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000209	0.0017	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—HTR1D—migraine	0.000208	0.00169	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—CALCA—migraine	0.000208	0.00169	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—HTR2C—migraine	0.000207	0.00169	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—HTR2B—migraine	0.000207	0.00169	CbGpPWpGaD
Guanabenz—Vomiting—Topiramate—migraine	0.000205	0.000599	CcSEcCtD
Guanabenz—Rash—Topiramate—migraine	0.000204	0.000594	CcSEcCtD
Guanabenz—Dermatitis—Topiramate—migraine	0.000203	0.000593	CcSEcCtD
Guanabenz—Headache—Topiramate—migraine	0.000202	0.00059	CcSEcCtD
Guanabenz—ADRA2B—Signaling by GPCR—HTR1D—migraine	0.000202	0.00165	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—EDNRA—migraine	0.000202	0.00164	CbGpPWpGaD
Guanabenz—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000195	0.00159	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—HTR7—migraine	0.000194	0.00158	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—CALCA—migraine	0.000194	0.00158	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000194	0.00158	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—HTR2B—migraine	0.000193	0.00157	CbGpPWpGaD
Guanabenz—Nausea—Topiramate—migraine	0.000192	0.00056	CcSEcCtD
Guanabenz—ADRA2C—Signaling by GPCR—HTR1D—migraine	0.000189	0.00154	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HTR2B—migraine	0.000188	0.00153	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—HTR7—migraine	0.000182	0.00148	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—HTR1B—migraine	0.000181	0.00148	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000179	0.00146	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HTR2B—migraine	0.000176	0.00143	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—HTR1A—migraine	0.000174	0.00142	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—TAC1—migraine	0.000172	0.0014	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—NPS—migraine	0.000172	0.0014	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—HTR1D—migraine	0.000169	0.00138	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—HTR2C—migraine	0.000168	0.00137	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000167	0.00136	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RAMP1—migraine	0.000164	0.00134	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CALCRL—migraine	0.000164	0.00134	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—EDNRA—migraine	0.000164	0.00133	CbGpPWpGaD
Guanabenz—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000158	0.00129	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CALCA—migraine	0.000158	0.00128	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—HTR2B—migraine	0.000157	0.00128	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RAMP1—migraine	0.000154	0.00125	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CALCRL—migraine	0.000154	0.00125	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HTR1D—migraine	0.000153	0.00125	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	0.000149	0.00122	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000149	0.00122	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—HTR7—migraine	0.000147	0.0012	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HTR2B—migraine	0.000143	0.00116	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CACNA1A—migraine	0.000139	0.00113	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—HTR2A—migraine	0.000136	0.00111	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000136	0.0011	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—HTR1B—migraine	0.000135	0.0011	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—HTR1A—migraine	0.00013	0.00106	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—TAC1—migraine	0.000128	0.00104	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—NPS—migraine	0.000128	0.00104	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—HTR2A—migraine	0.000127	0.00104	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—HTR1B—migraine	0.000126	0.00103	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—HTR2C—migraine	0.000125	0.00102	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CALCRL—migraine	0.000125	0.00102	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RAMP1—migraine	0.000125	0.00102	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HTR1B—migraine	0.000123	0.000998	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—EDNRA—migraine	0.000122	0.000994	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—HTR1A—migraine	0.000121	0.000988	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—TAC1—migraine	0.000119	0.000973	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—NPS—migraine	0.000119	0.000973	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR1D—migraine	0.000119	0.000973	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HTR1A—migraine	0.000118	0.00096	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CALCA—migraine	0.000117	0.000956	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—HTR2C—migraine	0.000117	0.000954	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—TAC1—migraine	0.000116	0.000946	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—NPS—migraine	0.000116	0.000946	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HTR1B—migraine	0.000114	0.000932	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—EDNRA—migraine	0.000114	0.000928	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HTR2C—migraine	0.000114	0.000928	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CACNA1A—migraine	0.000113	0.000921	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR1D—migraine	0.000112	0.000909	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR2B—migraine	0.000111	0.000904	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—EDNRA—migraine	0.000111	0.000902	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HTR1A—migraine	0.00011	0.000897	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—HTR7—migraine	0.00011	0.000895	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CALCA—migraine	0.00011	0.000893	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—TAC1—migraine	0.000108	0.000883	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—NPS—migraine	0.000108	0.000883	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CALCA—migraine	0.000107	0.000869	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HTR2C—migraine	0.000106	0.000866	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR2B—migraine	0.000104	0.000845	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—EDNRA—migraine	0.000103	0.000843	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—HTR2A—migraine	0.000103	0.000841	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—HTR7—migraine	0.000103	0.000836	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—HTR1B—migraine	0.000102	0.000834	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HTR7—migraine	9.98e-05	0.000812	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CALCA—migraine	9.96e-05	0.000811	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—HTR1A—migraine	9.85e-05	0.000802	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LRP1—migraine	9.78e-05	0.000796	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—TAC1—migraine	9.7e-05	0.00079	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—NPS—migraine	9.7e-05	0.00079	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—HTR2C—migraine	9.52e-05	0.000775	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HTR7—migraine	9.32e-05	0.000759	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HTR1B—migraine	9.29e-05	0.000757	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—EDNRA—migraine	9.26e-05	0.000754	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LRP1—migraine	9.13e-05	0.000744	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR1D—migraine	9.06e-05	0.000738	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HTR1A—migraine	8.95e-05	0.000729	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CALCA—migraine	8.91e-05	0.000726	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—NPS—migraine	8.81e-05	0.000718	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—TAC1—migraine	8.81e-05	0.000718	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HTR2C—migraine	8.64e-05	0.000704	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR2B—migraine	8.43e-05	0.000686	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—EDNRA—migraine	8.41e-05	0.000685	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—HTR7—migraine	8.33e-05	0.000679	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CALCA—migraine	8.09e-05	0.000659	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—HTR2A—migraine	7.69e-05	0.000627	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HTR7—migraine	7.57e-05	0.000616	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOTCH4—migraine	7.5e-05	0.000611	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LRP1—migraine	7.42e-05	0.000604	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR1B—migraine	7.24e-05	0.000589	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—HTR2A—migraine	7.19e-05	0.000585	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOTCH4—migraine	7.01e-05	0.000571	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HTR2A—migraine	6.99e-05	0.000569	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR1A—migraine	6.97e-05	0.000567	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TAC1—migraine	6.86e-05	0.000559	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NPS—migraine	6.86e-05	0.000559	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PGR—migraine	6.86e-05	0.000559	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR1B—migraine	6.76e-05	0.000551	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR2C—migraine	6.73e-05	0.000548	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EDNRA—migraine	6.54e-05	0.000533	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HTR2A—migraine	6.53e-05	0.000531	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR1A—migraine	6.51e-05	0.00053	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PGR—migraine	6.41e-05	0.000522	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NPS—migraine	6.41e-05	0.000522	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TAC1—migraine	6.41e-05	0.000522	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOTCH3—migraine	6.38e-05	0.000519	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CALCA—migraine	6.3e-05	0.000513	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR2C—migraine	6.28e-05	0.000512	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CACNA1A—migraine	6.24e-05	0.000508	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EDNRA—migraine	6.11e-05	0.000498	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOTCH3—migraine	5.96e-05	0.000485	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR7—migraine	5.89e-05	0.00048	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CALCA—migraine	5.88e-05	0.000479	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—HTR2A—migraine	5.84e-05	0.000475	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH4—migraine	5.69e-05	0.000463	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR7—migraine	5.5e-05	0.000448	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR1B—migraine	5.49e-05	0.000447	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HTR2A—migraine	5.3e-05	0.000432	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR1A—migraine	5.29e-05	0.00043	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TAC1—migraine	5.21e-05	0.000424	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NPS—migraine	5.21e-05	0.000424	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PGR—migraine	5.21e-05	0.000424	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR2C—migraine	5.1e-05	0.000416	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFBR2—migraine	5.07e-05	0.000413	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EDNRA—migraine	4.97e-05	0.000404	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH3—migraine	4.84e-05	0.000394	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CALCA—migraine	4.78e-05	0.000389	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFBR2—migraine	4.74e-05	0.000386	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—MTHFR—migraine	4.6e-05	0.000375	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR7—migraine	4.47e-05	0.000364	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR2A—migraine	4.13e-05	0.000336	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR2A—migraine	3.86e-05	0.000314	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFBR2—migraine	3.85e-05	0.000314	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MTHFR—migraine	3.74e-05	0.000305	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ESR1—migraine	3.66e-05	0.000298	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ESR1—migraine	3.42e-05	0.000279	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR2A—migraine	3.13e-05	0.000255	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ESR1—migraine	2.78e-05	0.000226	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTHFR—migraine	2.06e-05	0.000168	CbGpPWpGaD
